Testing MOUD Scale-Up

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT07224516
Status
Recruiting

Conditions

  • Correctional Institutions
  • Incarcerated Individuals

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • SAMHSA — BEHAVIORAL
    Implement the scale-up of MOUD
  • Learning Collaborative — BEHAVIORAL
    The LCs will include learning sessions at baseline and monthly coaching sessions thereafter in the 12 month intervention period to provide training and technical assistance on the study protocol, types of MOUD and their clinical effectiveness, strategies to reduce stigma towards MOUD, approaches to overcoming common MOUD implementation barriers, and strategies to increase use and reduce burden of MOUD.

Study Details

The goal of this clinical trial is to improve health outcomes for incarcerated individuals by increasing medications for opioid use disorder (MOUD) use, using scalable and cost-effective methods that could be applied more broadly in the criminal justice system.

Key Dates

Start date
Feb 5, 2026
Status verified
Feb 2026
Primary completion
Aug 31, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
120 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Substance Abuse and Mental Health Services Administration (SAMHSA) Policy Academy
    Departments of Corrections (DOCs) which previously completed the SAMHSA Policy Academy will be recruited for the Policy Academy.
  • Experimental: Multi-site Learning Collaborative (LC)
    The LCs will include learning sessions at baseline and monthly coaching sessions thereafter in the 12 month intervention period to provide training and technical assistance on the study protocol, types of MOUD and their clinical effectiveness, strategies to reduce stigma towards MOUD, approaches to overcoming common MOUD implementation barriers, and strategies to increase use and reduce burden of MOUD.
  • No Intervention: Practice as Usual
    This arm will conduct practice as usual, not using the updated MOUD practices.

Primary Outcome Measure

Reach of systems-change for scaling medications for MOUD [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Wisconsin-MadisonMadisonWisconsin53706
Jessica Vechinski
414-899-4324
Todd Molfenter, PhD (PRINCIPAL_INVESTIGATOR)
Rosemarie Martin, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Madison, WI

Related Studies